The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer
Abstract
Purpose: We assessed the impact of tumor regression grading (TRG) and its value in correlation to established prognostic factors in a cohort of rectal carcinoma patients treated by preoperative chemoradiotherapy (CRT). Patients and Methods: TRG was evaluated on surgical specimens of 385 patients treated within the preoperative CRT arm of the CAO/ARO/AIO-94 trial: 50.4 Gy was delivered, fluorouracil was given in the first and fifth week, and surgery was performed 6 weeks thereafter. TRG was determined by the amount of viable tumor versus fibrosis, ranging from TRG 4 when no viable tumor cells were detected, to TRG 0 when fibrosis was completely absent. TRG 3 was defined as regression more than 50% with fibrosis outgrowing the tumor mass, TRG 2 was defined as regression less than 50%, and TRG 1 was defined basically as a morphologically unaltered tumor mass. We performed an initially unplanned, hypothesis-generating analysis with respect to the prognostic value of this TRG system. Results: TRG 4, 3, 2, 1, 0 was found in 10.4%, 52.2%, 13.8%, 15.3%, and 8.3% of the resected specimens, respectively. Five-year disease-free survival (DFS) after CRT and curative resection was 86% for TRG 4, 75% for grouped TRG 2 + 3, and 63% for grouped TRG 0 + 1 (P = .006). On multivariate analysis, the pathologic T category and the nodal status after CRT were the most important independent prognostic factors for DFS. Conclusion: In this exploratory analysis, complete (TRG 4) and intermediate pathologic response (TRG 2 + 3) suggested improved DFS after preoperative CRT. TRG assessment should be implemented in pathologic evaluation and prospectively validated in further studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Sauer, R., Becker, H., Hohenberger, W., Rödel, C., Wittekind, C., Fietkau, R., Martus, P., Tschmelitsch, J., Hager, E., Hess, C. F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040694 · Cited by 6,050
Self-citationMandard, A.-M., Dalibard, F., Mandard, J.-C., Marnay, J., Henry-Amar, M., Petiot, J.-F., Roussel, A., Jacob, J.-H., Segol, P., Samama, G., et al. (1994) · Cancer · doi:10.1002/1097-0142(19940601)73:11<2680::aid-cncr2820731105>3.0.co;2-c · Cited by 2,044
Pathological features of rectal cancer after preoperative radiochemotherapy
Dworak, O., Keilholz, L., & Hoffmann, A. (1997) · International Journal of Colorectal Disease · doi:10.1007/s003840050072 · Cited by 1,338
Prolongation of the Disease-Free Interval in Surgically Treated Rectal Carcinoma
Gastrointestinal Tumor Study Group (1985) · New England Journal of Medicine · doi:10.1056/nejm198506063122301 · Cited by 1,130
Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy
Becker, K., Mueller, J. D., Schulmacher, C., Ott, K., Fink, U., Busch, R., Böttcher, K., Siewert, J. R., & Höfler, H. (2003) · Cancer · doi:10.1002/cncr.11660 · Cited by 827
Francois, Y., Nemoz, C. J., Baulieux, J., Vignal, J., Grandjean, J.-P., Partensky, C., Souquet, J. C., Adeleine, P., & Gerard, J.-P. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2396 · Cited by 815 · cited 1×
“Tumor regression is associated with treatment-related factors, such as overall doses of radiation, combination with chemotherapy, and the time interval between preoperative treatment and surgery.(14-16) Given that these factors were largely homogenous for all patients within our trial, it is likely that factors relate…”
BackgroundJanjan, N. A., Khoo, V. S., Abbruzzese, J., Pazdur, R., Dubrow, R., Cleary, K. R., Allen, P. K., Lynch, P. M., Glober, G., Wolff, R., et al. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00099-1 · Cited by 458
Vecchio, F. M., Valentini, V., Minsky, B. D., Padula, G. D. A., Venkatraman, E. S., Balducci, M., Miccichè, F., Ricci, R., Morganti, A. G., Gambacorta, M. A., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.11.017 · Cited by 423
Rödel, F., Hoffmann, J., Distel, L., Herrmann, M., Noisternig, T., Papadopoulos, T., Sauer, R., & Rödel, C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3028 · Cited by 292
Self-citationBouzourene, H., Bosman, F. T., Seelentag, W., Matter, M., & Coucke, P. (2002) · Cancer · doi:10.1002/cncr.10327 · Cited by 285
Cited by
Maas, M., Nelemans, P. J., Valentini, V., Das, P., Rödel, C., Kuo, L.-J., Calvo, F. A., García-Aguilar, J., Glynne-Jones, R., Haustermans, K., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70172-8 · Cited by 1,945
Self-citationWhat Is the Role for the Circumferential Margin in the Modern Treatment of Rectal Cancer?
Nagtegaal, I. D., & Quirke, P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7027 · Cited by 1,006
Roh, M. S., Colangelo, L. H., O'Connell, M. J., Yothers, G., Deutsch, M., Allegra, C. J., Kahlenberg, M. S., Baez-Diaz, L., Ursiny, C. S., Petrelli, N. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.0467 · Cited by 933
Gérard, J.-P., Azria, D., Gourgou-Bourgade, S., Martel-Laffay, I., Hennequin, C., Etienne, P.-L., Vendrely, V., François, E., de La Roche, G., Bouché, O., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.8376 · Cited by 747
Patel, U. B., Taylor, F., Blomqvist, L., George, C., Evans, H., Tekkis, P., Quirke, P., Sebag-Montefiore, D., Moran, B., Heald, R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.9068 · Cited by 703
Martin, S. T., Heneghan, H. M., & Winter, D. C. (2012) · British Journal of Surgery · doi:10.1002/bjs.8702 · Cited by 637
Blazer, D. G., Kishi, Y., Maru, D. M., Kopetz, S., Chun, Y. S., Overman, M. J., Fogelman, D., Eng, C., Chang, D. Z., Wang, H., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5299 · Cited by 604
Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer
Park, I. J., You, Y. N., Agarwal, A., Skibber, J. M., Rodriguez-Bigas, M. A., Eng, C., Feig, B. W., Das, P., Krishnan, S., Crane, C. H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.7901 · Cited by 485
Lefevre, J. H., Mineur, L., Kotti, S., Rullier, E., Rouanet, P., de Chaisemartin, C., Meunier, B., Mehrdad, J., Cotte, E., Desrame, J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.6049 · Cited by 483
Chau, I., Brown, G., Cunningham, D., Tait, D., Wotherspoon, A., Norman, A. R., Tebbutt, N., Hill, M., Ross, P. J., Massey, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.4875 · Cited by 474
FOxTROT Collaborative Group (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70348-0 · Cited by 473
Fokas, E., Liersch, T., Fietkau, R., Hohenberger, W., Beissbarth, T., Hess, C., Becker, H., Ghadimi, M., Mrak, K., Merkel, S., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.3769 · Cited by 454
Self-citationCapirci, C., Valentini, V., Cionini, L., De Paoli, A., Rodel, C., Glynne-Jones, R., Coco, C., Romano, M., Mantello, G., Palazzi, S., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.12.019 · Cited by 445
Nonoperative Management of Rectal Cancer With Complete Clinical Response After Neoadjuvant Therapy
Smith, J. D., Ruby, J. A., Goodman, K. A., Saltz, L. B., Guillem, J. G., Weiser, M. R., Temple, L. K., Nash, G. M., & Paty, P. B. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e3182759f1c · Cited by 418
Kasi, A., Abbasi, S., Handa, S., Al-Rajabi, R., Saeed, A., Baranda, J., & Sun, W. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.30097 · Cited by 388
Kalady, M. F., de Campos-Lobato, L. F., Stocchi, L., Geisler, D. P., Dietz, D., Lavery, I. C., & Fazio, V. W. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b91e63 · Cited by 386
Hong, Y. S., Nam, B.-H., Kim, K.-P., Kim, J. E., Park, S. J., Park, Y. S., Park, J. O., Kim, S. Y., Kim, T.-Y., Kim, J. H., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70377-8 · Cited by 383
You, Y. N., Hardiman, K. M., Bafford, A., Poylin, V., Francone, T. D., Davis, K., Paquette, I. M., Steele, S. R., & Feingold, D. L. (2020) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000001762 · Cited by 354
Das, P., Skibber, J. M., Rodriguez‐Bigas, M. A., Feig, B. W., Chang, G. J., Wolff, R. A., Eng, C., Krishnan, S., Janjan, N. A., & Crane, C. H. (2007) · Cancer · doi:10.1002/cncr.22625 · Cited by 332
Saigusa, S., Tanaka, K., Toiyama, Y., Yokoe, T., Okugawa, Y., Ioue, Y., Miki, C., & Kusunoki, M. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0617-z · Cited by 319
Valentini, V., Aristei, C., Glimelius, B., Minsky, B. D., Beets-Tan, R., Borras, J. M., Haustermans, K., Maingon, P., Overgaard, J., Pahlman, L., et al. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.06.027 · Cited by 300
Sainato, A., Cernusco Luna Nunzia, V., Valentini, V., De Paoli, A., Maurizi, E. R., Lupattelli, M., Aristei, C., Vidali, C., Conti, M., Galardi, A., et al. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.10.006 · Cited by 288
Ham, I.-H., Oh, H. J., Jin, H., Bae, C. A., Jeon, S.-M., Choi, K. S., Son, S.-Y., Han, S.-U., Brekken, R. A., Lee, D., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0972-8 · Cited by 264
Trakarnsanga, A., Gönen, M., Shia, J., Nash, G. M., Temple, L. K., Guillem, J. G., Paty, P. B., Goodman, K. A., Wu, A., Gollub, M., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju248 · Cited by 262
Quah, H., Chou, J. F., Gonen, M., Shia, J., Schrag, D., Saltz, L. B., Goodman, K. A., Minsky, B. D., Wong, W. D., & Weiser, M. R. (2008) · Cancer · doi:10.1002/cncr.23516 · Cited by 258
Zhou, H., Lin, C., Zhang, Y., Zhang, X., Zhang, C., Zhang, P., Xie, X., & Ren, Z. (2017) · Cell Proliferation · doi:10.1111/cpr.12341 · Cited by 98
Alternative clinical end points in rectal cancer—are we getting closer?
Glynne-Jones, R., Mawdsley, S., Pearce, T., & Buyse, M. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl173 · Cited by 88
Metadata
- Authors
- Rödel, C., Martus, P., Papadoupolos, T., Füzesi, L., Klimpfinger, M., Fietkau, R., Liersch, T., Hohenberger, W., Raab, R., Sauer, R., & Wittekind, C.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-12-01
- Volume
- 23
- Issue
- 34
- Pages
- 8688-8696
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2143655828
- Cited by
- 1,215
- References
- 26
- FWCI
- 16.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.